0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

An Evaluation of Some Clotting Tests in Patients Receiving Coumarin Drugs

WILLIAM J. MESSINGER, M.D.; MURRAY WEINER, M.D.
AMA Arch Intern Med. 1960;105(5):727-732. doi:10.1001/archinte.1960.00270170065007.
Text Size: A A A
Published online

The validity of the one-stage prothrombin estimation* as a guide to the control of coumarin-type anticoagulant therapy has been questioned periodically. The method has been criticized by some laboratory workers for poor reproducibility, and by some clinicians as being responsible for episodes of hemorrhage or active thromboembolism while the patient's prothrombin time has been reported in the "therapeutic range." There are experts who plead for more specific tests1-4 that measure proconvertin, "pure prothrombin," or Stuart factor. Others have described better methods to measure "coagulability" in general,5,6 using tests such as the "standard clotting time" or "heparin tolerance" test.

The clinician has been less concerned with the complex theories of coagulation than with the empirical clinical results of using a given test as a guide to the administration of anticoagulants. For example, if the presence of hematuria could be used by him as a quantitative guide for coumarin administration,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();